Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction

Area of Science:

• Cardiology
• Interventional Cardiology
• Heart Failure Management

Background:

• Severe ischemic left ventricular dysfunction (LVD) poses significant challenges in cardiovascular medicine.
• Optimal medical therapy (OMT) is the cornerstone of management, but revascularization strategies are debated.

Purpose of the Study:

• To review and compare coronary revascularization strategies against OMT in patients with severe ischemic LVD.
• To evaluate the efficacy of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in this patient population.

Main Methods:

• Review of the REVIVED-BCIS2 trial (PCI vs. OMT) and the STICH trial (CABG vs. OMT).
• Analysis of outcomes including mortality, heart failure hospitalizations, ejection fraction, and quality of life.

Main Results:

• REVIVED-BCIS2 found no significant difference between PCI + OMT and OMT alone in major adverse events or quality of life.
• STICH showed CABG + medical therapy reduced cardiovascular deaths and hospitalizations at 5 years, and all-cause mortality at 10 years.
• Current evidence suggests no benefit of PCI but improved outcomes with CABG in severe ischemic cardiomyopathy.

Conclusions:

• PCI does not appear to offer advantages over OMT in severe ischemic cardiomyopathy.
• CABG demonstrates long-term survival benefits in selected patients with ischemic cardiomyopathy.
• Further research and optimization of OMT are crucial pending more robust evidence on revascularization benefits.